Related Experiment Video
Updated: Jun 22, 2026
Development of an Insert Co-culture System of Two Cellular Types in the Absence of Cell-Cell Contact
Published on: July 17, 2016
Gng12 is a novel negative regulator of LPS-induced inflammation in the microglial cell line BV-2
Kelley C Larson1, Maciej Lipko, Michal Dabrowski
1Galenea Corporation, Cambridge, MA, USA. kelleyclarson@yahoo.com
Background:
Inflammation plays a central role in many neurodegenerative diseases, including Parkinson's, Alzheimer's, multiple sclerosis, amyotrophic lateral sclerosis, and AIDS dementia. Microglia are the resident macrophages of the central nervous system and are the cells primarily responsible for the inflammatory component of these diseases.
Methods:
Using gene expression profiling, we compared the profile of the neurospecific microglial cell line BV-2 after LPS stimulation to that of a macrophage cell line (J774A.1) stimulated with LPS.
Results:
A set of 77 genes that were modulated only in microglial cells after LPS stimulation was identified. One gene of interest, Gng12, was investigated further to determine its ability to modify the inflammatory response. Specifically, Gng12 mRNA levels were transiently increased after LPS stimulation. In addition, overall levels of Gng12 mRNA after LPS stimulation were significantly higher in BV-2 cells as compared to macrophage cells.
Conclusion:
Modulating Gng12 mRNA levels using RNAi revealed a novel role for the factor in the negative regulation of the overall inflammatory response as based on effects on nitrite and TNFalpha levels. These data suggest that Gng12 is a negative regulator of the LPS response and may be an important factor in the overall inflammatory signaling cascade.
Insights
Researchers identified Gng12 as a key regulator of neuroinflammation. Modulating Gng12 levels in microglia offers a potential therapeutic target for neurodegenerative diseases by reducing inflammatory responses.
Area of Science:
- Neuroscience
- Immunology
- Genetics
Background:
- Neuroinflammation is a critical factor in neurodegenerative diseases like Alzheimer's and Parkinson's.
- Microglia, the central nervous system's immune cells, drive this inflammation.
Purpose of the Study:
- To identify genes specifically modulated in microglia during inflammation.
- To investigate the role of the gene Gng12 in regulating the microglial inflammatory response.
Main Methods:
- Gene expression profiling of BV-2 microglial cells versus J774A.1 macrophage cells after LPS stimulation.
- Quantitative analysis of Gng12 mRNA levels.
- RNA interference (RNAi) to modulate Gng12 expression and assess inflammatory markers (nitrite, TNFalpha).
Main Results:
- Identified 77 genes uniquely modulated in microglia post-LPS stimulation.
- Gng12 mRNA levels were significantly higher and transiently increased in microglia compared to macrophages.
- Modulating Gng12 via RNAi reduced nitrite and TNFalpha levels, indicating a negative regulatory role.
Conclusions:
- Gng12 acts as a negative regulator of the lipopolysaccharide (LPS) response in microglia.
- Gng12 may be a crucial component of the inflammatory signaling cascade in the central nervous system.
- Targeting Gng12 presents a potential therapeutic strategy for neuroinflammatory conditions.
